ABOUT US

OUR STORY

In 2013, the Biomaterials and Bioengineering Laboratory of the French National Institute for Health and Medical Research (Inserm UMR 1121), co-directed by our CSO, Philippe LAVALLE, PhD discovered the antimicrobial properties of the anti-inflammatory coatings we were working on.

Between 2016 and 2018, we worked to develop our technology with the support of SATT Conectus .

In 2019, our CEO, Nihal Engin Vrana, PhD together with 2 collaborators, Philippe Lavalle, PhD and Angela Mutschler, PhD created SPARTHA Medical and were then incubated at SEMIA.

2020: TEAM UP

In 2020, the team has expanded with a production manager, Ms Cynthia Calligaro; a Business Developer, Dr Pulchérie Matsodoum Nguemté and a CFO, Mr Thierry Mignot.

We have been privileged to gather a multidisciplinary and experienced scientific advisory board.

In 2021, SPARTHA Medical obtained CIR accreditation for research and development (R&D) after scientific and technical expertise.

TEAM UP

SPARTHA Medical welcomed 4 new full-time staff:

Dr Baptiste Letellier as project manager, responsible for collaborative projects
Ms Lucie Lieu, as an apprentice engineer in biotechnology
Ms Yijie Li, a PhD candidate in mechanical engineering
Ms Ribsimé Mesropian, as an apprentice in marketing and communication

Enf of 2021, SPARTHA Medical is laureate of the EIC Accelerator. The EIC aims to stimulate Europe’s economic growth by enabling visionary and disruptive ideas to reach the market. This grant aims to help to deploy our innovation and start clinical evaluations. The project is called SPARTHACUS.